Concepedia

Two intermittent vismodegib dosing regimens in patients with multiple basal-cell carcinomas (MIKIE): a randomised, regimen-controlled, double-blind, phase 2 trial

Brigitte Dréno, Rainer Kunstfeld, Axel Hauschild, Scott W. Fosko, David Zloty, B. Labeille, Jean-Jacques Grob, Susana Puig, Frank Gilberg, Daniel Bergström,

The Lancet Oncology · 2017 · 206 citations · 6 references

DOI

Concepts

References

6

Efficacy and Safety of Vismodegib in Advanced Basal-Cell Carcinoma

Aleksandar Sekulić, Michael R. Migden, Anthony E. Oro et al. · New England Journal of Medicine · 2012 · 1.4K citations · Full text

, , +17

Inhibiting the Hedgehog Pathway in Patients with the Basal-Cell Nevus Syndrome

Jean Y. Tang, Julian Mackay‐Wiggan, Michelle Aszterbaum et al. · New England Journal of Medicine · 2012 · 547 citations · Full text

, , +17

Clinical Experience With Hedgehog Pathway Inhibitors

Jennifer A. Low, Frédéric J. de Sauvage · Journal of Clinical Oncology · 2010 · 174 citations

, , +17

Basal Cell Nevus Syndrome

William E. Clendenning · Archives of Dermatology · 1964 · 172 citations

, , +10

Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update (30-month) of the pivotal ERIVANCE BCC study.

Aleksandar Sekulić, Michael R. Migden, Nicole Basset‐Séguin et al. · Journal of Clinical Oncology · 2014 · 24 citations

, , +13